JEWETT, Anahid. First in Human Clinical Study Demonstrating the Safety and Efficacy of NK101 (supercharged NK cells) in the Treatment of Patients with Cancer. South East European Journal of Immunology, [S. l.], v. 8, n. CITIM, p. 040, 2025. DOI: 10.3889/seejim.2025.6102. Disponível em: https://seejim.eu/index.php/seejim/article/view/6102. Acesso em: 17 nov. 2026.